Stocks analysis

Analysis for LIN

  • 📈 Growth — 26/30
  • 💰 Profitability — 17/20
  • 🏦 Financial Health — 18/20
  • 💵 Valuation — 12/20
  • ⚠️ Risk — 5/10
Overall Score: 73/100

Summary:


📈 Growth & Financial Trajectory

Over the 8 quarters, LINDE's revenue rose from about $8.27B (2024-Q2) to about $8.78B (2026-Q1), a rough gain of 6%. Net income climbed from about $1.77B to $1.90B, up roughly 7%, with a generally steady trajectory despite periodic quarterly swings.

💰 Margins & Cash Flow

Gross margins hovered in the mid-20s (roughly 24-27%), with operating margins in the same band, indicating solid operating leverage. Operating cash flow remained strong, around $2.2B per quarter (Q1 2026 shows about $2.24B from operating activities), while net cash flow swung due to investing/financing activities.

🛡️ Balance Sheet & Liquidity

Total assets run in the $83-87B range; long-term debt around $19-21B and equity around $38-40B, yielding a comfortable equity buffer. Current assets about $13-14B against current liabilities around $14-16B suggest modest liquidity resilience.

⚠️ Key Drivers & Risks

  • Drivers: Industrial gas demand and capital-intensive plant expansion; manufacturing/healthcare cycle.
  • Risks: Cyclicality of industrial activity and energy markets; currency/valuation sensitivity; periodical funding swings.